CAR T-cell therapy has comparable efficacy with autologous transplantation in older adults with DLBCL in partial response-Reference-Cited by-同舟云学术

CAR T-cell therapy has comparable efficacy with autologous transplantation in older adults with DLBCL in partial response

Published:2023-10-02 Issue:19 Volume:7 Page:5937-5940
ISSN:2473-9529
Container-title:Blood Advances
language:en
Short-container-title:

Author:

Akhtar Othman S.¹,Cao Biwei²,Wang Xuefeng²^ORCID,Torka Pallawi³,Al-Jumayli Mohammed⁴,Locke Frederick L.¹,Freeman Ciara L.¹^ORCID

Affiliation:

1. 1Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL

2. 2Department of Bioinformatics and Biostatistics, Moffitt Cancer Center, Tampa, FL

3. 3Division of Hematological Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY

4. 4Senior Adult Oncology Program, Moffitt Cancer Center, Tampa, FL

Publisher

American Society of Hematology

Subject

Hematology

Link

https://ashpublications.org/bloodadvances/article-pdf/7/19/5937/2083690/blooda_adv-2023-010127-main.pdf

Reference12 articles.

1. National Cancer Institute . SEER Cancer Stat Facts: Non-Hodgkin Lymphoma. 2023. Accessed 3 August 2023. https://seer.cancer.gov/statfacts/html/nhl.html.

2. Outcomes of autologous hematopoietic cell transplantation in older patients with diffuse large B-cell lymphoma;Munshi;Transplant Cell Ther,2022

3. Toxicities of high-dose chemotherapy and autologous hematopoietic cell transplantation in older patients with lymphoma;Dahi;Blood Adv,2021

4. The benefit of CAR T cells in older patients;Bishop;Blood,2020

5. Outcomes of older patients in ZUMA-1, a pivotal study of axicabtagene ciloleucel in refractory large B-cell lymphoma;Neelapu;Blood,2020

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Outcomes and Toxicity in Older Adults Receiving Chimeric Antigen Receptor T Cell Therapy;Transplantation and Cellular Therapy;2024-05